Advanced search
Publication Cover
Journal of Medical Economics Volume 15, 2012 - Issue 2
Submit an article Journal homepage
1,001
Views
7
CrossRef citations to date
0
Altmetric
Research Article

Historical clinical and economic consequences of anemia management in patients with end-stage renal disease on dialysis using erythropoietin stimulating agents versus routine blood transfusions: a retrospective cost-effectiveness analysis

Huseyin NaciLondon School of Economics & Political Science LondonUKCorrespondence[email protected]
,
Gregory de LissovoyUnited BioSource Corporation MDUSA
,
Christopher HollenbeakPenn State College of Medicine PAUSA
,
Brian CusterBlood Systems Research Institute CAUSA
,
Axel HofmannMedical Society for Blood ManagementAustria
,
William McClellanEmory University School of Medicine GAUSA
&
Matthew GitlinAmgen Inc CAUSA
 show all
Pages 293-304 | Accepted 22 Nov 2011, Published online: 16 Dec 2011

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Omar Maoujoud, Samir Ahid & Yahia Cherrah. (2016) The cost-utility of treating anemia with continuous erythropoietin receptor activator or Epoetin versus routine blood transfusions among chronic hemodialysis patients. International Journal of Nephrology and Renovascular Disease 9, pages 35-43.
Read now
Barbara Riegel & George J Knafl. (2014) Electronically monitored medication adherence predicts hospitalization in heart failure patients. Patient Preference and Adherence 8, pages 1-13.
Read now

Articles from other publishers (5)

Nicole Brenner, Anuhya Kommalapati, Muhammad Ahsan & Anirban Ganguli. (2019) Red cell transfusion in chronic kidney disease in the United States in the current era of erythropoiesis stimulating agents. Journal of Nephrology 33:2, pages 267-275.
Crossref
Daniel M. Sugrue, Thomas Ward, Sukhvir Rai, Phil McEwan & Heleen G. M. van Haalen. (2019) Economic Modelling of Chronic Kidney Disease: A Systematic Literature Review to Inform Conceptual Model Design. PharmacoEconomics 37:12, pages 1451-1468.
Crossref
Yuan-gang Wu, Yi Zeng, Bin Shen, Hai-bo Si, Fei Cao, Ti-min Yang & Fu-xing Pei. (2016) Combination of Erythropoietin and Tranexamic Acid in Bilateral Simultaneous Total HIP Arthroplasty: A Randomised, Controlled Trial. HIP International 26:4, pages 331-337.
Crossref
Jacques Rottembourg, Patrick Tilleul, Gilbert Deray, Antoine Lafuma, Lorraine Zakin, Lamine Mahi & Jorge Wernli. (2014) Cost of managing anemia in end-stage renal disease: the experience of five French dialysis centers. The European Journal of Health Economics 16:4, pages 357-364.
Crossref
Thomas Ferguson, Yang Xu, Ravindi Gunasekara, Blake Lerner, Kerry Macdonald, Claudio Rigatto, Navdeep Tangri & Paul Komenda. (2015) The Cost Effectiveness of Erythropoietin-Stimulating Agents for Treating Anemia in Patients on Dialysis: A Systematic Review. American Journal of Nephrology 41:2, pages 89-97.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.